Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives

Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives

Saved in:

Bibliographic Details
Main Authors:	Lin Yong, Huang Ailong
Format:	Article
Language:	English
Published:	Science Press 2022-03-01
Series:	National Science Open
Online Access:	https://www.sciengine.com/doi/10.1360/nso/20220008
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
by: Qian He, et al.
Published: (2021-01-01)

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.
by: Tamara Elliott, et al.
Published: (2022-10-01)

Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination
by: Davide Torre, et al.
Published: (2025-05-01)

Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response
by: Ali Toloue Ostadgavahi, et al.
Published: (2021-05-01)

Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
by: Marija Vukčević, et al.
Published: (2024-12-01)

Safety and durability of the immune response after vaccination with the heterologous schedule of anti-COVID-19 vaccines SOBERANA®02 and SOBERANA® Plus in children 3–18 years old
by: Dagmar García-Rivera, et al.
Published: (2025-01-01)

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study
by: Nayab Batool Rizvi, et al.
Published: (2024-11-01)

Ethical concerns regarding heterologous COVID-19 vaccine administration
by: Somsri Wiwanitkit, et al.
Published: (2024-12-01)

Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination
by: Maaweya Awadalla, et al.
Published: (2025-01-01)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024-12-01)

Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
by: Zhifei Chen, et al.
Published: (2025-01-01)

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
by: Jialu Zhang, et al.
Published: (2021-01-01)

Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy
by: Süleyman Yıldırım, et al.
Published: (2024-04-01)

Long-term DNA methylation changes mediate heterologous cytokine responses after BCG vaccination
by: Cancan Qi, et al.
Published: (2025-07-01)

Expected Usefulness of Fourth Dose of COVID-19 Vaccine for Patients with Underlying Solid Tumor who Previously Received the Primary Heterologous COVID-19 Vaccine
by: Sora Yasri, et al.
Published: (2024-08-01)

Immune mechanisms mediating the heterologous effects of BCG vaccination: a systematic review
by: Louis Torracinta, et al.
Published: (2025-05-01)

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
by: Nungruthai Suntronwong, et al.
Published: (2023-12-01)

T cell immune memory after covid-19 and vaccination
by: Paul Klenerman, et al.
Published: (2023-10-01)

Comment on “Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis”
by: Amin Sharifan
Published: (2024-12-01)

Immune responses to Covid-19 vaccination in cancer patients
by: R. Campagna, et al.
Published: (2024-12-01)

Microneedle Delivery of Heterologous Microparticulate COVID-19 Vaccine Induces Cross Strain Specific Antibody Levels in Mice
by: Tanisha Manoj Arte, et al.
Published: (2025-04-01)

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice
by: Honghuan Li, et al.
Published: (2025-05-01)

Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines
by: Canjie Chen, et al.
Published: (2024-12-01)

The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients
by: Ji Young Park, et al.
Published: (2025-02-01)

Decade-Long Sustained Cellular Immunity Induced by Sequential and Repeated Vaccination with Four Heterologous HIV Vaccines in Rhesus Macaques
by: Xiaozhou He, et al.
Published: (2025-03-01)

Effectiveness of homologous and heterologous BNT162b2 and CoronaVac booster vaccination against severe COVID-19 outcomes
by: Masliyana Husin, et al.
Published: (2025-01-01)

Heterologous prime–boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models
by: Giuditta De Lorenzo, et al.
Published: (2025-04-01)

Modulation of the Immune Response by Nematode Secreted Acetylcholinesterase Revealed by Heterologous Expression in Trypanosoma musculi.
by: Rachel Vaux, et al.
Published: (2016-11-01)

Could Parental Vaccine Hesitancy in Childhood Immunization Programs Increase After COVID-19 Vaccines?
by: Mehmet Semih Demirtaş
Published: (2025-04-01)

Comparing the immune response and protective effect of COVID-19 vaccine under different vaccination strategies
by: Tianyi Zhao, et al.
Published: (2023-12-01)

Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine
by: Daniel O’Connor, et al.
Published: (2025-07-01)

Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients
by: Nicolas Gemander, et al.
Published: (2024-03-01)

Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens
by: Masanori Isogawa, et al.
Published: (2025-05-01)

Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses
by: Engin Berber, et al.
Published: (2024-11-01)

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization
by: Dongdong Li, et al.
Published: (2025-03-01)

Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines
by: Yandong Cheng, et al.
Published: (2025-12-01)

A Prospective Study of Immune Response After COVID-19 or Vaccination and Correlation Between Avidity Index and Neutralizing Capacity
by: Emma Löfström, et al.
Published: (2025-01-01)

Effect of heterologous intranasal iNCOVACC® vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial
by: Venkateshwar Rao Akula, et al.
Published: (2025-04-01)

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-10-01)

Parental vaccine hesitancy toward routine childhood immunizations and COVID-19 vaccines in Japan: A cross-sectional study
by: Aya Saitoh, et al.
Published: (2024-11-01)